78 related articles for article (PubMed ID: 7648833)
1. Comparison of three methods of antifungal susceptibility testing with the proposed NCCLS standard broth macrodilution assay: lack of effect of phenol red. National Committee for Clinical Laboratory Standards.
Sugar AM; Liu X
Diagn Microbiol Infect Dis; 1995 Mar; 21(3):129-33. PubMed ID: 7648833
[TBL] [Abstract][Full Text] [Related]
2. [Colorimetric broth microdilution for antifungal susceptibility testing].
Yamane N; Tosaka M; Okazawa Y
Rinsho Byori; 1996 Jan; 44(1):67-75. PubMed ID: 8691643
[TBL] [Abstract][Full Text] [Related]
3. A rapid microplate method for the proliferation assay of fungi and the antifungal susceptibility testing using the colorimetric microbial viability assay.
Tsukatani T; Suenaga H; Shiga M; Matsumoto K
Lett Appl Microbiol; 2014 Aug; 59(2):184-92. PubMed ID: 24713101
[TBL] [Abstract][Full Text] [Related]
4. Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis [2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide], for antifungal susceptibility testing of Aspergillus species.
Meletiadis J; Mouton JW; Meis JF; Bouman BA; Donnelly PJ; Verweij PE;
J Clin Microbiol; 2001 Dec; 39(12):4256-63. PubMed ID: 11724829
[TBL] [Abstract][Full Text] [Related]
5. Multicenter evaluation of commercial frozen plates for microdilution broth antifungal susceptibility testing of yeasts and comparison of MIC limits recommended in NCCLS M27-A2.
Makimura K; Oguri T; Mikami Y; Kume H; Hanazawa R; Abe M; Ikeda R; Shinoda T
Microbiol Immunol; 2005; 49(2):97-106. PubMed ID: 15722594
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
Gupta AK; Kohli Y
Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
[TBL] [Abstract][Full Text] [Related]
7. Standardization of antifungal susceptibility testing and clinical relevance.
Espinel-Ingroff A; Barchiesi F; Hazen KC; Martinez-Suarez JV; Scalise G
Med Mycol; 1998; 36 Suppl 1():68-78. PubMed ID: 9988494
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of chromoblastomycosis and phaeohyphomycosis agents to antifungal drugs.
Caligiorne RB; Resende MA; Melillo PH; Peluso CP; Carmo FH; Azevedo V
Med Mycol; 1999 Dec; 37(6):405-9. PubMed ID: 10647121
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of a colorimetric method for testing antifungal drug susceptibilities of Aspergillus species to voriconazole.
Yamaguchi H; Uchida K; Nagino K; Matsunaga T
J Infect Chemother; 2002 Dec; 8(4):374-7. PubMed ID: 12525904
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi.
Espinel-Ingroff A
J Clin Microbiol; 2001 Apr; 39(4):1360-7. PubMed ID: 11283057
[TBL] [Abstract][Full Text] [Related]
11. Is antifungal susceptibility testing useful in guiding fluconazole therapy?
Ghannoum MA
Clin Infect Dis; 1996 May; 22 Suppl 2():S161-5. PubMed ID: 8722845
[TBL] [Abstract][Full Text] [Related]
12. Antifungal susceptibility testing method for resource constrained laboratories.
Khan S; Singhal S; Mathur T; Upadhyay DJ; Rattan A
Indian J Med Microbiol; 2006 Jul; 24(3):171-6. PubMed ID: 16912435
[TBL] [Abstract][Full Text] [Related]
13. Utility of 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenyl-amino)carbonyl]-2H-tetrazolium hydroxide (XTT) and minimum effective concentration assays in the determination of antifungal susceptibility of Aspergillus fumigatus to the lipopeptide class compounds.
Hawser SP; Jessup C; Vitullo J; Ghannoum MA
J Clin Microbiol; 2001 Jul; 39(7):2738-41. PubMed ID: 11427611
[TBL] [Abstract][Full Text] [Related]
14. Multicenter comparison of a colorimetric microdilution broth method with the reference macrodilution method for in vitro susceptibility testing of yeast isolates.
Pfaller MA; Buschelman B; Bale MJ; Lancaster M; Espinel-Ingroff A; Rex JH; Rinaldi MG
Diagn Microbiol Infect Dis; 1994 May; 19(1):9-13. PubMed ID: 7956018
[TBL] [Abstract][Full Text] [Related]
15. In vitro antifungal susceptibility methods and clinical implications of antifungal resistance.
Espinel-Ingroff A; Warnock DW; Vazquez JA; Arthington-Skaggs BA
Med Mycol; 2000; 38 Suppl 1():293-304. PubMed ID: 11204157
[TBL] [Abstract][Full Text] [Related]
16. Antifungal susceptibility testing: progress and future developments.
Pfaller MA
Braz J Infect Dis; 2000 Apr; 4(2):55-60. PubMed ID: 11012296
[TBL] [Abstract][Full Text] [Related]
17. Colorimetric broth microdilution method for the antifungal screening of plant extracts against yeasts.
Liu M; Seidel V; Katerere DR; Gray AI
Methods; 2007 Aug; 42(4):325-9. PubMed ID: 17560320
[TBL] [Abstract][Full Text] [Related]
18. Rapid susceptibility testing of medically important zygomycetes by XTT assay.
Antachopoulos C; Meletiadis J; Roilides E; Sein T; Walsh TJ
J Clin Microbiol; 2006 Feb; 44(2):553-60. PubMed ID: 16455912
[TBL] [Abstract][Full Text] [Related]
19. Comparison between the standardized clinical and laboratory standards institute M38-A2 method and a 2,3-Bis(2-Methoxy-4-Nitro-5-[(Sulphenylamino)Carbonyl]-2H-tetrazolium hydroxide- based method for testing antifungal susceptibility of dermatophytes.
Shehata AS; Mukherjee PK; Ghannoum MA
J Clin Microbiol; 2008 Nov; 46(11):3668-71. PubMed ID: 18832129
[TBL] [Abstract][Full Text] [Related]
20. Antifungal susceptibility testing of Candida species by flow cytometry.
Lee W; Kwak Y
J Korean Med Sci; 1999 Feb; 14(1):21-6. PubMed ID: 10102519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
